NCT02191761View on ClinicalTrials.gov

Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 19, 2014

Primary Completion Date

May 20, 2015

Study Completion Date

May 20, 2015

Conditions
Colorectal CancerGastric CancerHepatic CancerPancreatic Cancer
Interventions
DRUG

SM04755

Escalating Doses

Trial Locations (3)

77030

Houston

85258

Scottsdale

92121

La Jolla

Sponsors
All Listed Sponsors
lead

Biosplice Therapeutics, Inc.

INDUSTRY